Inhibitors of the molybdenum cofactor containing 4-hydroxybenzoyl-CoA reductase Journal Article


Authors: Johannes, J.; Unciuleac, M. C.; Friedrich, T.; Warkentin, E.; Ermler, U.; Boll, M.
Article Title: Inhibitors of the molybdenum cofactor containing 4-hydroxybenzoyl-CoA reductase
Abstract: 4-Hydroxybenzoyl-CoA reductase (4-HBCR) is a member of the xanthine oxidase (XO) family of molybdenum cofactor containing enzymes and catalyzes the irreversible removal of a phenolic hydroxy group by reduction, yielding benzoyl-CoA and water. In this work the effects of various activity modulating compounds were characterized by kinetic, electron paramagnetic resonance (EPR) spectroscopic, and X-ray crystallographic studies. 4-HBCR was readily inactivated by cyanide and by the reducing agents titanium(III) citrate and dithionite; in contrast, reduced viologens had no inhibitory effect. Cyanide inhibition occurred in both the oxidized and reduced state of 4-HBCR. In the reduced state, cyanide-inhibited 4-HBCR was reactivated by simple oxidation. In contrast, reactivation from the oxidized state was only achieved in the presence of sulfide. Dithionite-inhibited 4-HBCR was reactivated by oxidation, whereas inhibition by titanium(III) citrate was irreversible. The previously reported inhibitory effect of azide could not be confirmed; instead, azide rather protected the enzyme from inactivation by titanium(III) citrate. The EPR spectra of the Mo(V) states were nearly identical in the noninhibited methyl viologen and in the dithionite-inhibited states of 4-HBCR; they exhibited a hyperfine splitting due to magnetic coupling with two solvent-exchangeable protons. The cyanide-treated enzyme showed the typical desulfo-inhibited Mo(V) EPR signal in D2O, whereas in H2O the hyperfine splitting was altered but indicated no loss of Mo(V)-proton interactions. The structures of dithionite- and azide-bound 4-HBCR were solved at 2.1 and 2.2 Å, respectively. Both dithionite and azide bound directly to equatorial ligation sites of the Mo atom. The results obtained revealed further insights into the active site of an unusual member of the XO family of molybdenum cofactor containing enzymes. © 2008 American Chemical Society.
Keywords: unclassified drug; metabolism; enzyme inhibition; enzymology; enzyme inhibitor; chemistry; drug antagonism; kinetics; enzyme inhibitors; enzyme inactivation; citric acid; crystallography, x-ray; chemical structure; cyanide; molecular interaction; water; enzyme kinetics; protein family; x ray crystallography; oxidoreductase; xanthine oxidase; oxidation reduction reaction; oxidation-reduction; enzyme mechanism; titanium derivative; sulfide; enzyme active site; solvent; coenzyme; coenzymes; hydroxyl group; anions; anion; electron paramagnetic resonance spectroscopy; electron spin resonance; metalloproteins; molybdenum cofactors; biocatalysts; paramagnetic resonance; reaction kinetics; molybdenum compounds; 4 hydroxybenzoyl coenzyme a reductase; azide; benzoyl coenzyme a; coenzyme a; deuterium oxide; molybdenum; phenol; titanium citrate; viologen; benzoyl coenzyme a 4 oxidoreductase; benzoyl-coenzyme a-4-oxidoreductase; enzyme activator; metalloprotein; molybdenum cofactor; pteridine derivative; thauera; azides; electron spin resonance spectroscopy; enzyme reactivators; oxidoreductases acting on ch-ch group donors; pteridines
Journal Title: Biochemistry
Volume: 47
Issue: 17
ISSN: 0006-2960
Publisher: American Chemical Society  
Date Published: 2008-01-01
Start Page: 4964
End Page: 4972
Language: English
DOI: 10.1021/bi800137v
PUBMED: 18393440
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 17 November 2011" - "CODEN: BICHA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mihaela Carmen Sandu
    19 Sandu